Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
News
markets
stocks
Laurus Labs Ltd
Laurus Labs Ltd

Laurus Labs Ltd (LAURUSLABS) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 19,38,492
Apr 23, 2025 15:11 IST Open
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹650.10
₹-1.60 (-0.15%)
641.95Low
Today’s Performance
659.85High
385.45Low
52 Week’s Performance
659.85High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-0.15%
  • 1 Week4.25%
  • 1 Month4.61%
  • 3 Months14.16%
  • 6 Months45.31%
  • 1 Year51.54%
  • 3 Years2.35%
  • 5 Years47.37%

bt_logoPeer Comparison

Laurus Labs Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Cipla Ltd
Price

₹650.75

Laurus Labs Ltd

₹1,782.90

Sun Pharmaceutical Industries Ltd

₹5,916.50

Divis Laboratories Ltd

₹1,530.80

Cipla Ltd

bt_logoStock Summary

  • Face Value (₹)2.00
  • Beta1.23
  • 52-Week Low (₹)385.45
  • 52-Week High (₹)657.40
  • Price-to-Book (X)*8.50
  • Dividend Yield (%)0.12
  • Price-to-Earnings (P/E) (X)*175.65
  • Earnings Per Share (₹)3.71
  • Market Cap (₹ Cr.)*35,143.08
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Pahalgam Terror Attack: Tourists Shot, Newlyweds Targeted | Tragedy In Kashmir2:47Pahalgam Terror Attack: Tourists Shot, Newlyweds Targeted | Tragedy In Kashmir
HCL Tech, Infosys, Wipro Outlook After Earnings | Kiran Jani’s Take1:18HCL Tech, Infosys, Wipro Outlook After Earnings | Kiran Jani’s Take
‘I Don’t Know Whether To Laugh Or Cry’ : Gaurang Shah Calls Out Trump’s Economic Chaos2:27‘I Don’t Know Whether To Laugh Or Cry’ : Gaurang Shah Calls Out Trump’s Economic Chaos
US VP JD Vance Calls For Enhanced Trade Ties With India, Says Crucial For 21st Century2:19US VP JD Vance Calls For Enhanced Trade Ties With India, Says Crucial For 21st Century
JD Vance’s Family Experience The Warmth Of India: From Bonding With PM Modi To Jaipur’s History3:19JD Vance’s Family Experience The Warmth Of India: From Bonding With PM Modi To Jaipur’s History
US-India Defense Partnership: Vance Promotes Advanced Military Tech And F-35 Jets For India5:25US-India Defense Partnership: Vance Promotes Advanced Military Tech And F-35 Jets For India
US-India Trade Deal| JD Vance Urges India To Ease Non-Tariff Barriers For US Market Access3:15US-India Trade Deal| JD Vance Urges India To Ease Non-Tariff Barriers For US Market Access
Trump: Won’t Play Hardball With China, Tariffs Will Be Nowhere Near 145%3:03Trump: Won’t Play Hardball With China, Tariffs Will Be Nowhere Near 145%
America And India Have Officially Finalised The Terms Of Reference For The Trade Negotiation3:56America And India Have Officially Finalised The Terms Of Reference For The Trade Negotiation
Best Flagship Phone In 2025? AI Anchor Sana Explains2:55Best Flagship Phone In 2025? AI Anchor Sana Explains
View more

bt_logoFinancial Analysis

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

bt_logoRatio Analysis

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

bt_logoShare Holding Pattern

Summary (As on 31 Mar 2025)
Promoters (27.62%)
FII (27.51%)
DII (11.77%)
Public & Others (24.84%)
Government Holding (0.00%)
Corporate Holding (8.26%)

bt_logoDeals

14 Nov, 2022SELL
ISHARES CORE EMERGING MARKETS MAURITIUS CO
Qty529337
Average Price₹455.4
14 Nov, 2022BUY
ISHARES CORE MSCI EMERGING MARKETS ETF
Qty529337
Average Price₹455.4
03 Nov, 2022SELL
ISHARES CORE EMERGING MARKETS MAURITIUS CO
Qty529338
Average Price₹476.6
03 Nov, 2022BUY
ISHARES CORE MSCI EMERGING MARKETS ETF
Qty529338
Average Price₹476.6
25 Oct, 2022BUY
ISHARES CORE MSCI EMERGING MARKETS ETF
Qty284783
Average Price₹479.8
25 Oct, 2022SELL
ISHARES CORE EMERGING MARKETS MAURITIUS CO
Qty284783
Average Price₹479.8
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.

bt_logoFAQ's

What was Laurus Labs Ltd share price previously?
Laurus Labs Ltd share price was down by -0.15% from the previous closing price of ₹651.70.
Who are peers of Laurus Labs Ltd?
The peers of Laurus Labs Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Laurus Labs Ltd?
The promotor/promotors of Laurus Labs Ltd are CHAVA SATYANARAYANA, VENKATA RAVI KUMAR VANTARAM, Aruna Bhinge, Rajesh Koshy Chandy, Ravindranath Kancherla, Venkata Lakshmana Rao Chunduru, Karnam Sekar, KRISHNA CHAITANYA CHAVA, G Venkateswar Reddy, Soumya Chava, Ramesh Subrahmanian.
What has been 52-week high of Laurus Labs Ltd stocks?
The highest price of Laurus Labs Ltd stock is ₹657.40 in the last 52-week.
What is the share price of Laurus Labs Ltd (LAURUSLABS) today on NSE?
As on Apr 23, 2025 Laurus Labs Ltd (LAURUSLABS)’s share price on NSE is Rs 650.1
What is the market cap of Laurus Labs Ltd (LAURUSLABS)?
The current market capitalisation of Laurus Labs Ltd (LAURUSLABS) is 35,143.08 crores
What is Laurus Labs Ltd Share symbol?
The symbol of Laurus Labs Ltd is LAURUSLABS.
What is the PE ratio of Laurus Labs Ltd (LAURUSLABS)?
The current PE ratio of Laurus Labs Ltd (LAURUSLABS) is 175.65.
What is the PB ratio of Laurus Labs Ltd (LAURUSLABS)?
The current PB ratio of Laurus Labs Ltd (LAURUSLABS) is 8.50.
Today’s High & Low share prices of Laurus Labs Ltd (LAURUSLABS) on NSE?
Today, the share price of Laurus Labs Ltd (LAURUSLABS) on NSE touched a high of Rs 659.85 and a low of Rs 641.95
What price did Laurus Labs Ltd (LAURUSLABS) shares open on the NSE today?
On NSE, the share price of Laurus Labs Ltd (LAURUSLABS) opened at Rs 656.8
What is the 52-week high of Laurus Labs Ltd (LAURUSLABS)?
The 52-week high price of Laurus Labs Ltd (LAURUSLABS) is Rs 659.85
What is the 52-week low of Laurus Labs Ltd (LAURUSLABS)?
The 52-week low price of Laurus Labs Ltd (LAURUSLABS) is Rs 385.45

bt_logoAbout Laurus Labs

Laurus Labs Ltd, incorporated in the year 2005, has its registered office in Plot No 21 Jawaharlal Nehru, Pharma City Parawada, Visakhapatnam, Andhra Pradesh, 531021, 91-891-3061222, 91-891-3061270. The main industry in which Laurus Labs Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Laurus Labs Ltd is/are Deloitte Haskins & Sells LLP. In the main management, Ravindranath Kancherla is chairman and G Venkateswar Reddy is the company secretary for Laurus Labs Ltd.

  • CS
    CHAVA SATYANARAYANAExecutive Director & CEO
  • VRKV
    VENKATA RAVI KUMAR VANTARAMExecutive Director & CFO
  • AB
    Aruna BhingeIndependent Director
  • RKC
    Rajesh Koshy ChandyIndependent Director
  • RK
    Ravindranath KancherlaChairman & Independent Directo
  • VLRC
    Venkata Lakshmana Rao ChunduruExecutive Director
  • KS
    Karnam SekarIndependent Director
  • KCC
    KRISHNA CHAITANYA CHAVAExecutive Director
  • GVR
    G Venkateswar ReddyVice President & CS
  • SC
    Soumya ChavaExecutive Director
  • RS
    Ramesh SubrahmanianIndependent Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.